http://www.gpo.gov/fdsys/pkg/CFR-2000-title45-vol4/xml/CFR-2000-title45-vol4.xml
http://en.wikipedia.org/wiki/Risk
http://www.heritage.org/research/reports/2004/05/compromising-quality-the-high-cost-of-government-drug-purchasing
http://www.fdic.gov/regulations/safety/manual/section4-1.html
http://www.policymed.com/drug-shortages/
http://www.patentdocs.org/2010/02/reverse-payments-in-generic-drug-settlements-part-ii.html
http://www.nlm.nih.gov/nichsr/edu/healthecon/glossary.html
http://www.encyclopedia.com/topic/Substance_abuse.aspx
http://www.zurinstitute.com/riskmanagement.html
http://www.biospace.com/news_story.aspx?StoryID=225159
http://www.cwru.edu/med/epidbio/mphp439/Risk_Management.htm
http://www.fdic.gov/regulations/safety/manual/section3-2.html
http://qbdworks.com/risk-assessment-for-qbd-fmea-fails/
https://www.scribd.com/doc/44480542/LP-Formulation-Problems-and-Solutions
http://en.wikipedia.org/wiki/Credit_risk
http://kaiserhealthnews.org/Features/Insuring-Your-Health/2012/cancer-drugs-by-pill-instead-of-IV-Michelle-Andrews-051512.aspx
http://www.patentdocs.org/2014/11/judge-sheridan-dismisses-more-plaintiffs-in-lipitor-antitrust-case.html
http://www.nursingceu.com/courses/380/index_nceu.html
http://www.fda.gov/NewsEvents/Testimony/ucm115007.htm
http://www.drugstudy.md/quiz.html
http://www.prnewswire.com/news-releases/fda-accepts-endo-pharmaceuticals-complete-response-for-new-formulation-of-opana-er-124445678.html
http://www.policymed.com/2014/10/drug-shortages-update.html
http://www.hhs.gov/healthcare/rights/law/index.html
http://www.slideshare.net/PostgradoMLCC/quality-riskmanagement-qas1037618082010
http://www.hc-sc.gc.ca/dhp-mps/compli-conform/gmp-bpf/docs/gui-0023-eng.php
http://www.ajhp.org/content/66/5_Supplement_3/s20.full
http://www.masstortdefense.com/tags/drug/
http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html
http://www.opioids.com/oxycodone/oxycontin.htm
http://www.guideline.gov/content.aspx?id=47023
http://finance.yahoo.com/news/fda-accepts-review-otsuka-pharmaceutical-130000091.html
http://www.vtmd.org/risk-management
http://hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/clini/cta_amendment-eng.php
http://www.ipsspecials.com/specials/drug-tariff/faqs
http://www.oasisadvancedwellness.com/learning/cancer-doctors-perscribe-dubious-drugs.html
